William Steinkrauss
First SEC filing: April 1, 2019 · Latest: April 1, 2019
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Jan. 29, 2022 | CRIS | A | 360,000 | · | · | 360,000 Direct | · | Acquired | (price as of 2026-10-06) |
| Jan. 28, 2021 | CRIS | A | 180,000 | · | · | 180,000 Direct | · | Acquired | (price as of 2026-10-06) |
| March 2, 2020 | CRIS | A | 385,000 | · | · | 385,000 Direct | · | Acquired | (price as of 2026-10-06) |
| Sept. 10, 2019 | CRIS | A | 125,000 | · | · | 125,000 Direct | · | Acquired | (price as of 2026-10-06) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Jan. 29, 2022 | CRIS | Employee stock option (right to buy) | Common stock | $3.09 | Jan. 28, 2032 | 360,000 | Acquired |
| Jan. 28, 2021 | CRIS | Employee stock option (right to buy) | Common stock | $9.14 | Jan. 27, 2031 | 180,000 | Acquired |
| March 2, 2020 | CRIS | Employee stock option (right to buy) | Common stock | $1.26 | March 1, 2030 | 385,000 | Acquired |
| Sept. 10, 2019 | CRIS | Employee stock option (right to buy) | Common stock | $1.96 | Sept. 10, 2029 | 125,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 5 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| April 1, 2019 | CRIS | Common Stock | 9,767 | Direct |
| April 1, 2019 | CRIS | Employee stock option (right to buy) | 16,000 | Direct |
| April 1, 2019 | CRIS | Employee stock option (right to buy) | 11,220 | Direct |
| April 1, 2019 | CRIS | Employee stock option (right to buy) | 15,400 | Direct |
| April 1, 2019 | CRIS | Employee stock option (right to buy) | 115,000 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2021 | $400,231 | · | · | · | $171,200 | · | $18,838 | $1,899,445 |
| 2020 | $352,135 | · | · | · | $201,960 | · | $15,761 | $891,755 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.